ClinicalTrials.gg
Status unknownNCT00300833Updated Aug 11, 2011

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

A Phase 4 interventional study of Tirofiban in Acute Myocardial Infarction, sponsored by The Baruch Padeh Medical Center, Poriya. Status unknown at 2 sites in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-08-11.

Sponsored by The Baruch Padeh Medical Center, Poriya · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2009), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

02

Conditions studied

  • Acute Myocardial Infarction
03

In context

Lead sponsor

The Baruch Padeh Medical Center, Poriya is the lead sponsor of 41 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion criteria

Exclusion Criteria:

  • women less than 50 years old and 80 years old, bleeding tendency, stroke in the past
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Interventions

06

What researchers measure

Primary outcomes

  1. mortality

    Time frame: immidiately

Secondary outcomes

  1. TIMI flow

    feeling better

    Time frame: 24 hours

07

Study locations

2 of 2 sites recruiting
  • Cardiovascular Division, The Baruch Padeh Medical Center, Poriya,
    Tiberias, 15208, Israel
    Recruiting
  • Magen David ,
    Tiberias, Israel
    • Sergay Krablikov, Dr · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00300833
Lead sponsor
The Baruch Padeh Medical Center, Poriya
First posted
Mar 10, 2006
Start date
Jan 2006
Primary completion
Jan 2012 (estimated)
Last update
Aug 11, 2011

Study contacts

Yonathan Hasin, Professor
Contact
yhasin@poria.health.gov.il
97246652648
Menachem Naheer
study chair · The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tirofiban

Start the discussion